Zydus Lifesciences Gets USFDA Nod for MS Drug; Oncology Plant Cleared, Shares Flat
Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 952.95 on 14th November, even as the company announced it...
Tag : Zydus Lifesciences
Zydus Lifesciences Board Approves Rs 84 Crore Acquisition of Sterling Biotech API Business; Shares Trading Flat
Shares of Zydus Lifesciences Ltd. are trading flat after reaching a day’s high of Rs 1,125 on 17th September, following the board’s approval of the...
Zydus Lifesciences Ltd Q1 Report; Profit Rise 2-Folds; Shares Slump 2%
Shares of Zydus Lifesciences Ltd on Friday, 11 August, were trading in the red even after the company reported a two-fold rise in consolidated net...
Anupam Rasayan, Zee and Zydus Lifesciences Among Top Stocks to Watch Today
The domestic equity indices ended the last trading on a high. BSE Sensex ended 418 points higher, while Nifty gained 114 points. Today, both indices...
Zydus Lifesciences Gets USFDA Approval for Smoking Addiction Treating Drug
Ahmedabad-headquartered pharmaceutical company Zydus Lifesciences announced on Tuesday that it has received approval for manufacturing and marketing a generic version of Varenicline tablets from the...
Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug
Shares of Zydus Lifesciences hit a 52-week high in morning trade on April 19 after the company said it had received final approval from the...
Zydus Lifesciences Shares Rise After USFDA Approves Tofacitinib Tablets
Shares of Zydus Lifesciences were trading in the early hours of March 22, after the company’s subsidiary received USFDA approval for tofacitinib tablets. Zydus Pharmaceuticals...
Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High
Zydus Lifesciences’ drug hit an eight-month high following a string of US regulatory approvals. The stock hit Rs 426 on the NSE on October 7...
Zydus Lifesciences’ Generic Drug Mirabegron for Overactive Bladder Gets USFDA Nod
On Monday, Zydus Lifesciences said it received the USFDA’s (United States Food and Drug Administration) final nod to market its version of Mirabegron extended-release tablets...
Zydus Receives USFDA Approval for Generic Antacid
On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....